Search Results for " Vemurafenib "
Vemurafenib Related Products
Vemurafenib is a targeted cancer therapy used in the treatment of certain types of melanoma, particularly BRAF V600E-mutant melanoma. It is a BRAF inhibitor, meaning it specifically targets and blocks a mutated form of the BRAF protein that is often found in cancer cells.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Vemurafenib, pharmacopeial and non-pharmacopeial Vemurafenib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Vemurafenib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Vemurafenib-related products are thoroughly characterized. Vemurafenib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.